Mata Nathan L.'s Form 4 filing
Belite Bio, Inc (BLTE) · filed Apr 24, 2026
- Accession no.
- 0001193125-26-177293
- Filed
- Apr 24, 2026
- Trade date
- Apr 23, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $166.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mata Nathan L.CIK 0002013987 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | American depositary share | SSaleDisposed | −267 | $164.47F3 | −$43,913.49 | 10,399 | Direct | |
| Apr 23, 2026 | American depositary share | SSaleDisposed | −158 | $165.38F4 | −$26,130.04 | 10,241 | Direct | |
| Apr 23, 2026 | American depositary share | SSaleDisposed | −127 | $166.56F5 | −$21,153.12 | 10,114 | Direct | |
| Apr 23, 2026 | American depositary share | SSaleDisposed | −373 | $167.37F6 | −$62,429.01 | 9,741 | Direct | |
| Apr 23, 2026 | American depositary share | SSaleDisposed | −54 | $168.43F7 | −$9,095.22 | 9,687 | Direct | |
| Apr 23, 2026 | American depositary share | SSaleDisposed | −21 | $169.56F8 | −$3,560.76 | 9,666 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of shares sold at prices that ranged from $164.03 to $164.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $165.02 to $165.915. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of shares sold at prices that ranged from $166 to $166.9. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of shares sold at prices that ranged from $167.01 to $167.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average price of shares sold at prices that ranged from $168.15 to $168.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents the weighted average price of shares sold at prices that ranged from $169.55 to $169.69. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.